|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/18 | |||
| C07K 16/46 | |||
| A61K 39/395 | |||
| C12N 15/13 | |||
| G01N 33/577 | |||
| A61P 37/06 | |||
| A61P 19/02 |
| (11) | Patento numeris | 1558647 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03776676.3 |
| Europos patento paraiškos padavimo data | 2003-11-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-08-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-06-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/BE2003/000192 |
| Data | 2003-11-07 |
| (87) | Numeris | WO 2004/041862 |
| Data | 2004-05-21 |
| (30) | Numeris | Data | Šalis |
| 425073 P | 2002-11-08 | US | |
| 425063 P | 2002-11-08 | US | |
| 03447005 | 2003-01-10 | EP | |
| PCT/EP03/06581 | 2003-06-23 | WO | |
| PCT/EP03/07313 | 2003-07-08 | WO |
| (72) |
SILENCE, Karen, BE
LAUWEREYS, Marc, BE
DE HAARD, Hans, NL
|
| (73) |
Ablynx N.V.,
Technologiepark 21, 9052 Ghent-Zwijnaarde,
BE
|
| (54) | SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOUR NECROSIS FACTOR-ALPHA AND USES THEREFOR |
| SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOUR NECROSIS FACTOR-ALPHA AND USES THEREFOR |